Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) to Ring The Nasdaq Stock Market Opening Bell

What: Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients, will visit the Nasdaq MarketSite in Times Square.

In honor of the occasion, David Stack, Chief Executive Officer and Chairman, will ring the Opening Bell. 

Where:Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:Wednesday, February 3, 2016 – 9:15 a.m. to 9:30 a.m. ET          

Pacira Pharmaceuticals Media Contact:Amber Sears(973) [e-mail]

Nasdaq MarketSite:Emily Pan(646) [e-mail]

Feed Information:Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK

Social Media:For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:http://www.facebook.com/NASDAQ.

For photos from ceremonies and events visit our Instagram Page:http://instagram.com/nasdaq

For news tweets, please visit our Twitter page at:http://twitter.com/nasdaq

For exciting viral content and ceremony photos visit our Tumblr Page:http://nasdaq.tumblr.com/

Webcast: A LiveStream of the Nasdaq Opening Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos: To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About PaciraPacira Pharmaceuticals, Inc. (Nasdaq:PCRX) is a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company’s flagship product, EXPAREL® (bupivacaine liposome injectable suspension), indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia, was commercially launched in the United States in April 2012. EXPAREL and two other products have successfully utilized DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. Additional information about Pacira is available at www.pacira.com.

About NasdaqNasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.6 trillion and nearly 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

-NDAQA-